National Institute on Drug Abuse (NIDA) is the lead federal agency supporting scientific research on drug use and its consequences. Our mission is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health through:
- Strategically supporting and conducting basic and clinical research on drug use, its consequences, and the underlying neurobiological, behavioral, and social mechanisms involved.
- Ensuring the effective translation, implementation, and dissemination of scientific research findings to improve the prevention and treatment of substance use disorders and enhance public awareness of addiction as a brain disorder.
To enhance the pool of underrepresented populations in the sciences, the National Institute on Drug Abuse established the Office of Diversity and Health Disparities (ODHD) 20 years ago. The mission of the ODHD is to strengthen the NIDA extramural research portfolio through a more diverse and robust extramural research workforce, attracting and retaining talented individuals from all populations in order to fulfill the mission of NIDA.
Underrepresented researchers face a number of challenges that influence their success in obtaining independent funding support. To that end, NIDA has implemented several key early stage outreach programs which play a vital role at recruiting, training, and retaining researchers from underrepresented backgrounds in order to develop and support their research careers. In addition, NIDA has a Diversity Consortium that includes staff across NIDA Scientific Divisions and Offices who help guide the direction of activities related to diversity within the institute and who promote diversity in the extramural community.
- Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (ENDURE) (R25 Clinical Trial Not Allowed)
- Research Supplements to Promote Diversity In Health-Related Research (Admin Supp Clinical Trial Not Allowed)